Suivre
Rita Azevedo
Rita Azevedo
Post-doctoral researcher
Adresse e-mail validée de ipoporto.min-saude.pt
Titre
Citée par
Citée par
Année
Protein glycosylation and tumor microenvironment alterations driving cancer hallmarks
A Peixoto, M Relvas-Santos, R Azevedo, LL Santos, JA Ferreira
Frontiers in oncology 9, 380, 2019
2422019
Emerging antibody-based therapeutic strategies for bladder cancer: A systematic review
R Azevedo, JA Ferreira, A Peixoto, M Neves, N Sousa, A Lima, LL Santos
Journal of controlled release 214, 40-61, 2015
1522015
Hypoxia enhances the malignant nature of bladder cancer cells and concomitantly antagonizes protein O-glycosylation extension
A Peixoto, E Fernandes, C Gaiteiro, L Lima, R Azevedo, J Soares, ...
Oncotarget 7 (39), 63138, 2016
792016
SLC19A1, SLC46A1 and SLCO1B1 Polymorphisms as Predictors of Methotrexate-Related Toxicity in Portuguese Rheumatoid Arthritis Patients
A Lima, M Bernardes, R Azevedo, J Monteiro, H Sousa, R Medeiros, ...
Toxicological Sciences 142 (1), 196-209, 2014
712014
Future perspectives of Smartphone applications for rheumatic diseases self-management
R Azevedo, H Sousa, J Monteiro, A Lima
Rheumatology international 35 (3), 419-431, 2015
672015
Targeted O‐glycoproteomics explored increased sialylation and identified MUC16 as a poor prognosis biomarker in advanced‐stage bladder tumours
S Cotton, R Azevedo, C Gaiteiro, D Ferreira, L Lima, A Peixoto, ...
Molecular oncology 11 (8), 895-912, 2017
642017
Current approaches for TYMS polymorphisms and their importance in molecular epidemiology and pharmacogenetics
A Lima, R Azevedo, H Sousa, V Seabra, R Medeiros
Pharmacogenomics 14 (11), 1337-1351, 2013
542013
Role of key TYMS polymorphisms on methotrexate therapeutic outcome in portuguese rheumatoid arthritis patients
A Lima, V Seabra, M Bernardes, R Azevedo, H Sousa, R Medeiros
PloS one 9 (10), e108165, 2014
532014
CD44 glycoprotein in cancer: a molecular conundrum hampering clinical applications
R Azevedo, C Gaiteiro, A Peixoto, M Relvas-Santos, L Lima, LL Santos, ...
Clinical proteomics 15, 1-5, 2018
512018
Sialyl-Tn identifies muscle-invasive bladder cancer basal and luminal subtypes facing decreased survival, being expressed by circulating tumor cells and metastases
L Lima, M Neves, MI Oliveira, L Dieguez, R Freitas, R Azevedo, C Gaiteiro, ...
Urologic Oncology: Seminars and Original Investigations 35 (12), 675. e1-675. e8, 2017
492017
Pharmacogenomics of methotrexate membrane transport pathway: can clinical response to methotrexate in rheumatoid arthritis be predicted?
A Lima, M Bernardes, R Azevedo, R Medeiros, V Seabra
International journal of molecular sciences 16 (6), 13760-13780, 2015
492015
Prediction of methotrexate clinical response in Portuguese rheumatoid arthritis patients: implication of MTHFR rs1801133 and ATIC rs4673993 polymorphisms
A Lima, J Monteiro, M Bernardes, H Sousa, R Azevedo, V Seabra, ...
BioMed research international 2014, 2014
472014
Smartphone application for rheumatoid arthritis self-management: cross-sectional study revealed the usefulness, willingness to use and patients’ needs
R Azevedo, M Bernardes, J Fonseca, A Lima
Rheumatology international 35, 1675-1685, 2015
462015
SLC19A1 80G allele as a biomarker of methotrexate-related gastrointestinal toxicity in Portuguese rheumatoid arthritis patients
A Lima, M Bernardes, H Sousa, R Azevedo, L Costa, F Ventura, V Seabra, ...
Pharmacogenomics 15 (6), 807-820, 2014
462014
Moving toward personalized medicine in rheumatoid arthritis: SNPs in methotrexate intracellular pathways are associated with methotrexate therapeutic outcome
A Lima, M Bernardes, R Azevedo, V Seabra, R Medeiros
Pharmacogenomics 17 (15), 1649-1674, 2016
452016
Over forty years of bladder cancer glycobiology: Where do glycans stand facing precision oncology?
R Azevedo, A Peixoto, C Gaiteiro, E Fernandes, M Neves, L Lima, ...
Oncotarget 8 (53), 91734, 2017
432017
Genetic polymorphisms in low-dose methotrexate transporters: current relevance as methotrexate therapeutic outcome biomarkers
A Lima, H Sousa, J Monteiro, R Azevedo, R Medeiros, V Seabra
Pharmacogenomics 15 (12), 1611-1635, 2014
372014
Exploring sialyl-Tn expression in microfluidic-isolated circulating tumour cells: A novel biomarker and an analytical tool for precision oncology applications
M Neves, R Azevedo, L Lima, MI Oliveira, A Peixoto, D Ferreira, J Soares, ...
New biotechnology 49, 77-87, 2019
362019
Glycan affinity magnetic nanoplatforms for urinary glycobiomarkers discovery in bladder cancer
R Azevedo, J Soares, C Gaiteiro, A Peixoto, L Lima, D Ferreira, ...
Talanta 184, 347-355, 2018
332018
Circulating tumor cells in bladder cancer: Emerging technologies and clinical implications foreseeing precision oncology
R Azevedo, J Soares, A Peixoto, S Cotton, L Lima, LL Santos, JA Ferreira
Urologic oncology: seminars and original investigations 36 (5), 221-236, 2018
282018
Le système ne peut pas réaliser cette opération maintenant. Veuillez réessayer plus tard.
Articles 1–20